Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer

Sarah J Zardawi1, Sandra A O'Toole, Robert L Sutherland

  • 1Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, Australia.

Insights

Advances in breast cancer treatment have reduced mortality, but new therapies are needed for aggressive subtypes. This review explores Hedgehog, Notch, and Wnt pathways as potential novel therapeutic targets for breast cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Breast cancer mortality has decreased due to screening and targeted therapies like tamoxifen and trastuzumab.
  • Significant challenges remain in treating aggressive breast cancer subtypes lacking estrogen receptor (ER) or Her2 expression, such as basal-like carcinomas.
  • Novel therapeutic targets are crucial for improving outcomes in poor-prognosis breast cancer groups.

Purpose of the Study:

  • To review the current evidence for dysregulation of Hedgehog, Notch, and Wnt signaling pathways in breast cancer.
  • To propose these pathways as potential novel therapeutic targets for breast cancer treatment.

Main Methods:

  • Literature review of current evidence on signaling pathway aberrations in breast cancer.
  • Analysis of the role of Hedgehog, Notch, and Wnt pathways in normal development and stem cell regulation.
  • Exploration of the implications of pathway dysregulation in breast cancer pathogenesis.

Main Results:

  • Hedgehog, Notch, and Wnt signaling pathways are essential for normal development and stem cell maintenance.
  • Aberrations in these pathways are increasingly implicated in the development and progression of various malignancies, including breast cancer.
  • Evidence suggests these pathways are dysregulated in aggressive breast cancer subtypes.

Conclusions:

  • The Hedgehog, Notch, and Wnt signaling pathways represent promising novel therapeutic targets for breast cancer.
  • Targeting these pathways could lead to improved treatment strategies for aggressive and difficult-to-treat breast cancer forms.
  • Further research into targeting these pathways is warranted to enhance breast cancer treatment outcomes.

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...